# Mineralys Therapeutics, Inc.: Form 8-K, filed Jun 3, 2026

- Company: [Mineralys Therapeutics, Inc.](/companies/mlys.md) (CIK 1933414)
- Form: 8-K
- Filed: 2026-06-03
- Accepted by EDGAR: Jun 3, 2026, 06:02 ET
- Period: 2026-06-02
- Accession: 0001628280-26-040024
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1933414/000162828026040024/mlys-20260602.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1933414/000162828026040024/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1933414/000162828026040024/mlys-20260602.htm

Filed Jun 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-040024. Last ingested by Listed: Nov 4, 2026, 19:22 ET. No prices; not investment advice.